EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues
Coya Therapeutics, Inc. (COYA) had EBIT Margin of -152.30% for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$3.96M |
|
$-5.71M |
|
-- |
|
$3.96M |
|
$9.99M |
|
$-6.03M |
|
$0.33M |
|
$-5.71M |
|
$-5.71M |
|
$-5.71M |
|
$-5.71M |
|
$-5.71M |
|
$-5.71M |
|
$-6.03M |
|
$-6.02M |
|
16.73M |
|
16.73M |
|
$-0.34 |
|
$-0.34 |
|
| Balance Sheet Financials | |
$49.94M |
|
$0.01M |
|
$0.01M |
|
$49.95M |
|
$5.87M |
|
-- |
|
$1.05M |
|
$6.92M |
|
$43.03M |
|
$43.03M |
|
$43.03M |
|
20.93M |
|
| Cash Flow Statement Financials | |
$-10.74M |
|
$-1.16M |
|
$20.39M |
|
$38.34M |
|
$46.82M |
|
$8.48M |
|
$4.29M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.50 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-152.30% |
|
|
EBIT Margin |
-152.30% |
-- |
|
-144.08% |
|
-144.16% |
|
$-11.90M |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
-- |
|
-- |
|
-- |
|
-13.27% |
|
-13.27% |
|
-11.43% |
|
-13.27% |
|
$2.06 |
|
$-0.71 |
|
$-0.64 |
|